Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion type Assertion NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_head.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion description "[Furthermore, ICV leptin injections were able to decrease neuropeptide Y (NPY) levels in the arcuate and paraventricular hypothalamic nuclei in both lean and genetically obese fa/fa rats, although a higher leptin dose was again needed in the obese group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion evidence source_evidence_literature NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion SIO_000772 8826985 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion wasDerivedFrom befree-2016 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.
- NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_assertion wasGeneratedBy ECO_0000203 NP1358462.RAahqvRhsZmhGfLjuMSClktl-QP43xBQgupW0Tn6wiyrI130_provenance.